drugset / Trial / NCT07266558
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID-19.
Timeline
- Start
- 2025-11-26
- Primary completion
- 2027-06-16
- Completion
- 2027-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elasomeran | Messenger RNA (mRNA) | — | Intramuscular |
| Subject | mRNA-1283 | Messenger RNA (mRNA) | — | Intramuscular |